Subject category:
Finance, Accounting and Control
Published by:
Harvard Business Publishing
Version: 7 November 2006
Length: 16 pages
Data source: Published sources
Share a link:
https://casecent.re/p/190548
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
This is a Portuguese version. Hedge fund SAC Capital and analysts from Gradient Analytics and Banc of America face charges of stock price manipulation from Biovail, a Canadian pharmaceutical company. Gradient and BofA produced negative reports on Biovail's earnings quality. At the same time, SAC built a large short position in the stock. The defendants must consider specific and general strategic responses to these allegations.
Location:
Industry:
Size:
USD1 billion revenues; 1,700 employees
Other setting(s):
2006
About
Abstract
This is a Portuguese version. Hedge fund SAC Capital and analysts from Gradient Analytics and Banc of America face charges of stock price manipulation from Biovail, a Canadian pharmaceutical company. Gradient and BofA produced negative reports on Biovail's earnings quality. At the same time, SAC built a large short position in the stock. The defendants must consider specific and general strategic responses to these allegations.
Settings
Location:
Industry:
Size:
USD1 billion revenues; 1,700 employees
Other setting(s):
2006